Studies in thyroid tumors suggest that Metformin increases p AMPK, reduces mTOR phosphorylation, downregulates S6K1/S6 signaling, and inhibits cyclin D1 and c MYC via the mTOR pathway. Here, CCND1 is linked to thyroid tumor.